TAPROSTENESODIUM
-
TAPROSTENESODIUM
structure -
-
CAS No:
87440-45-7
-
Formula:
C24H29O5.Na
-
Chemical Name:
TAPROSTENESODIUM
-
Synonyms:
Sodium 3-[(Z)-[(3aR,4R,5R,6aS)-4-[(1E,3S)-3-cyclohexyl-3-hydroxy-1-propenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-ylidene]methyl]benzoate;taprostene sodium salt;Rheocyclan, Sodium 3-[(Z)-[(3aR,4R,5R,6aS)-4-[(1E,3S)-3-cyclohexyl-3-hydroxy-1-propenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-ylidene]methyl]benzoate;3-[[(2Z,3aR)-4β-[(1E,3S)-3-Cyclohexyl-3-hydroxy-1-propenyl]-3,3aβ,4,5,6,6aβ-hexahydro-5α-hydroxy-2H-cyclopenta[b]furan-2-ylidene]methyl]benzenecarboxylic acid sodium salt;CG-4203;2,3,4-Trinor-1,5-inter-2-phenylene-6,9-epoxy-11,15-dihydroxy-15-dihydroxy-15-cyclohexyl-(16,17,18,19,20-pentanor)prosta-5,13-dienoate;Benzoic acid, 3-((4-(3-cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2H-cyclopenta(B)furan-2-ylidene)methyl)-, monosodium salt, (3ar-(2Z,3aalpha,4alpha(1E,3S*),5beta,6aalpha))-;Benzoic acid, 3-((Z)-((3ar,4R,5R,6as)-(4-((1E,3S)-3-cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2H-cyclopenta(B)furan-2-ylidene)methyl)-, monosodium salt
- Categories:
-
CAS No:
Characteristics
89.82000
2.67430
173-182.5 °C(lit.)
609.4ºC
209.2ºC
2-8ºC
LD50 in mice, rats (mg/kg): 164, 20 i.v. (Schneider)
Safety Information
3
20/21/22
36
Xn
P280
H302; H312; H332
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)
2,3,4-trinor-1,5-inter-2-phenylene-6,9-epoxy-11,15-dihydroxy-15-dihydroxy-15-cyclohexyl-(16,17,18,19,20-pentanor)prosta-5,13-dienoate
Computed Properties
Molecular Weight:420.5
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:5
Exact Mass:420.19126830
Monoisotopic Mass:420.19126830
Topological Polar Surface Area:89.8
Heavy Atom Count:30
Complexity:642
Defined Atom Stereocenter Count:5
Defined Bond Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
10-hydroxy-10-(3-octa-2,5-dienyloxiran-2-yl)deca-5,8-dienoic acid
103188-12-1
-
(5E,9E)-8-hydroxy-10-[3-[(2E,5E)-octa-2,5-dienyl]oxiran-2-yl]deca-5,9-dienoic acid
103188-13-2
-
(4-benzamidophenyl) (Z)-7-[(1R,2R,3R)-3-hydroxy-2-(2-hydroxy-3-phenoxypropoxy)-5-oxocyclopentyl]hept-4-enoate
106342-69-2
-
20-dimethyl-7-thiaprostaglandin E1 methyl ester Formula
111037-12-8
-
11-deoxyprostaglandin E1 4-hydroxyphenyl ester Formula
114495-95-3
-
16,18-ethano-20-ethyl-6-oxoprostaglandin E1 leucinamide Formula
115288-30-7
-
(5S,6Z,8E,10E,12R,14Z)-5,12-Dihydroxy-20-oxo-6,8,10,14-eicosatetraenoic acid Structure
115609-68-2
-
EP 171 Structure
115825-93-9
-
What is 5,12,19-trihydroxyicosa-6,8,10,14-tetraenoic acid
117605-61-5
-
What is (E)-7-[5-chloro-2-[(E)-3-cyclohexyl-3-hydroxyprop-1-enyl]-3-hydroxycyclopentyl]hept-5-enoic acid
117708-11-9
Request for Quotation